Evaluating Label Warnings, Switching Rates in Patients With Psoriasis Initiating New Treatment
Posters presented at the 2023 Fall Clinical Dermatology Conference evaluated how label warnings may affect new treatment initiation and real-word switching patterns for patients starting risankizumab.
Dr Mona Shahriari Talks Unique Challenges in Treating Psoriasis in Patients With Skin of Color
Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology, discusses unique challenges dermatologists face when treating patients with skin of color, who may present differently from White patients.
Dr Afreen Idris Shariff: Cancer Care Can Transform Through e-Consults
Afreen Shariff, MD, MBBS, Duke Cancer Institute, discusses the challenges and benefits of electronic consults (e-consults) for patients with cancer currently undergoing treatment who have a comorbidity history or who develop an endocrine system disorder because of treatment.
Dr Brian Mullen Highlights Patient Education, Cost-Effectiveness Strategies in Digital Health
Brian Mullen, PhD, head of innovation and product at The Clinic by Cleveland Clinic, shares his expertise in providing easy-to-use digital health platforms for patients, while maintaining the cost-effectiveness of these innovations.
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Dr Mona Shahriari Discusses Treatment of Plaque Psoriasis in Patients With Skin of Color
Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology, provides on overview of the treatment landscape in patients with skin of color with plaque psoriasis.
Allina Health’s Mike Koroscik on Revolutionizing Early Cancer Detection Through Technology
Through the integration of a population health reimbursement model in 2020, Allina Health Cancer Institute was able to implement expanded screening initiatives through the use of artificial intelligence and precision medicine, according to Mike Koroscik, MBA, MHA, vice president of oncology, Allina Health.
Racial, Ethnic Disparities Seen in Breast Cancer Survival, Even Among Clinical Trial Participants
It is critical to understand the role race and ethnicity play in survival for patients with early-stage breast cancer (eBC), as well as explore potential interventions to close these gaps.
Burnout Decreases Quality of Life in Both Patients and Clinicians in Reproductive Health Fields
Posters presented at the American Society for Reproductive Medicine (ASRM) 2023 Scientific Congress & Expo addressed psychosocial symptoms and burdens faced by both embryologists and women of color with uterine fibroids.
Dr Brian Mullen Shares Digital Health Advancements at The Clinic by Cleveland Clinic
Brian Mullen, PhD, head of innovation and product at The Clinic by Cleveland Clinic, discusses the implementation of digital health tools and strategies made by The Clinic and what these improvements mean for its patients.